Title | Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Jeitner TM, Kristoferson E, Azcona JA, Pinto JT, Stalnecker C, Erickson JW, Kung HF, Li J, Ploessl K, Cooper AJL |
Journal | J Fluor Chem |
Volume | 192 |
Issue | A |
Pagination | 58-67 |
Date Published | 2016 12 |
ISSN | 0022-1139 |
Abstract | Two 4-fluoro-L-glutamine diastereoisomers [(2,4)-4-FGln, (2,4)-4-FGln] were previously developed for positron emission tomography. Label uptake into two tumor cell types was greater with [F](2,4)-4-FGln than with [F](2,4)-4-FGln. In the present work we investigated the enzymology of two diastereoisomers of 4-FGln, two diastereoisomers of 4-fluoroglutamate (4-FGlu) (potential metabolites of the 4-FGln diastereoisomers) and another fluoro-derivative of L-glutamine [(2,4)-4-(3-fluoropropyl)glutamine (FP-Gln)]. The two 4-FGlu diastereoisomers were found to be moderate-to-good substrates relative to L-glutamate of glutamate dehydrogenase, aspartate aminotransferase and alanine aminotransferase. Additionally, alanine aminotransferase was shown to catalyze an unusual γ-elimination reaction with both 4-FGlu diastereoisomers. Both 4-FGlu diastereoisomers were shown to be poor substrates, but strong inhibitors of glutamine synthetase. Both 4-FGln diastereoisomers were shown to be poor substrates compared to L-glutamine of glutamine transaminase L and α-aminoadipate aminotransferase. However, (2,4)-4-FGln was found to be a poor substrate of glutamine transaminase K, whereas (2,4)-4-FGln was shown to be an excellent substrate. By contrast, FP-Gln was found to be a poor substrate of all enzymes examined. Evidently, substitution of H in position 4 by F in L-glutamine/L-glutamate has moderate-to-profound effects on enzyme-catalyzed reactions. The present results: 1) show that 4-FGln and 4-FGlu diastereoisomers may be useful for studying active site topology of glutamate- and glutamine-utilizing enzymes; 2) provide a framework for understanding possible metabolic transformations in tumors of F-labeled (2,4)-4-FGln, (2,4)-4-FGln, (2,4)-4-FGlu or (2,4)-4-FGlu; and 3) show that [F]FP-Gln is likely to be much less metabolically active than are the [F]4-FGln diastereoisomers. |
DOI | 10.1016/j.jfluchem.2016.10.008 |
Alternate Journal | J Fluor Chem |
PubMed ID | 28546645 |
PubMed Central ID | PMC5440087 |
Grant List | R01 CA164490 / CA / NCI NIH HHS / United States |
Related Institute:
Molecular Imaging Innovations Institute (MI3)